ZBH ZIMMER BIOMET HOLDINGS INC.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Zimmer Biomet Holdings, Inc.

Levi & Korsinsky announces it has commenced an investigation of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) concerning possible violations of federal securities laws by certain officers and directors.

On October 31, 2016 Zimmer stock dropped following the Company’s announcement that it was reducing its full-year forecast for 2016 from a previous estimate of $7.71 billion to between $7.63 billion and $7.65 billion. To obtain additional information about the investigation, go to:

http://zlk.9nl.com/zimmer-biomet-zbh

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
01/11/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZIMMER BIOMET HOLDINGS INC.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Zimmer Biomet Holdings, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 March 2025 in which we reassessed the appropriateness of the ratings in the...

Moody's Ratings assigns Baa2 rating to Zimmer's new senior unsecured n...

Moody's Ratings (Moody's) assigned a Baa2 rating to Zimmer Biomet Holdings, Inc. ("Zimmer") proposed $3 billion senior unsecured notes. At the same time, we assigned a (P)Baa2 rating to Zimmer's senior unsecured shelf registration. There are no changes to the existing Baa2 senior unsecured rating. T...

Moody's Ratings says Zimmer's acquisition of Paragon 28, Inc. raises l...

Moody's Ratings (Moody's) said that the announcement by Zimmer Biomet Holdings, Inc. ("Zimmer") that it intends to acquire Paragon 28, Inc. ("Paragon 28") will raise leverage but will aid in future growth and further diversify the company's overall business. There is no impact on Zimmer's ratings in...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch